77 related articles for article (PubMed ID: 31771949)
1. Pharmacokinetics of Organic Cation Transporter 1 (OCT1) Substrates in Oct1/2 Knockout Mice and Species Difference in Hepatic OCT1-Mediated Uptake.
Morse BL; Kolur A; Hudson LR; Hogan AT; Chen LH; Brackman RM; Sawada GA; Fallon JK; Smith PC; Hillgren KM
Drug Metab Dispos; 2020 Feb; 48(2):93-105. PubMed ID: 31771949
[TBL] [Abstract][Full Text] [Related]
2. Irinotecan Alters the Disposition of Morphine Via Inhibition of Organic Cation Transporter 1 (OCT1) and 2 (OCT2).
Zhu P; Ye Z; Guo D; Xiong Z; Huang S; Guo J; Zhang W; Polli JE; Zhou H; Li Q; Shu Y
Pharm Res; 2018 Oct; 35(12):243. PubMed ID: 30361780
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of a Biguanide Scaffold Enhances Drug Uptake by Organic Cation Transporters 1 and 2.
Obianom ON; Coutinho AL; Yang W; Yang H; Xue F; Shu Y
Mol Pharm; 2017 Aug; 14(8):2726-2739. PubMed ID: 28699756
[TBL] [Abstract][Full Text] [Related]
4. Selective Inhibition of Organic Cation Transporter 1 by Benzoylpaeoniflorin Attenuates Hepatic Lipid Accumulation through AMPK Activation.
Bi Y; Wang X; Han L; Tian Y; Bo T; Li C; Shi B; Gui C; Zhang Y
J Nat Prod; 2023 Jan; 86(1):191-198. PubMed ID: 36563333
[TBL] [Abstract][Full Text] [Related]
5. Role of organic cation transporter 1, OCT1 in the pharmacokinetics and toxicity of cis-diammine(pyridine)chloroplatinum(II) and oxaliplatin in mice.
Li S; Chen Y; Zhang S; More SS; Huang X; Giacomini KM
Pharm Res; 2011 Mar; 28(3):610-25. PubMed ID: 21104302
[TBL] [Abstract][Full Text] [Related]
6. Organic cation transporter 1 (OCT1) modulates multiple cardiometabolic traits through effects on hepatic thiamine content.
Liang X; Yee SW; Chien HC; Chen EC; Luo Q; Zou L; Piao M; Mifune A; Chen L; Calvert ME; King S; Norheim F; Abad J; Krauss RM; Giacomini KM
PLoS Biol; 2018 Apr; 16(4):e2002907. PubMed ID: 29659562
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of promiscuous substrate transport by Organic Cation Transporter 1.
Zeng YC; Sobti M; Quinn A; Smith NJ; Brown SHJ; Vandenberg JI; Ryan RM; O'Mara ML; Stewart AG
Nat Commun; 2023 Oct; 14(1):6374. PubMed ID: 37821493
[TBL] [Abstract][Full Text] [Related]
8. Renoprotective Effects of Metformin are Independent of Organic Cation Transporters 1 &2 and AMP-activated Protein Kinase in the Kidney.
Christensen M; Jensen JB; Jakobsen S; Jessen N; Frøkiær J; Kemp BE; Marciszyn AL; Li H; Pastor-Soler NM; Hallows KR; Nørregaard R
Sci Rep; 2016 Oct; 6():35952. PubMed ID: 27782167
[TBL] [Abstract][Full Text] [Related]
9. Influence of Cation Transporters (OCTs and MATEs) on the Renal and Hepatobiliary Disposition of [
Hernández-Lozano I; Mairinger S; Sauberer M; Stanek J; Filip T; Wanek T; Ciarimboli G; Tournier N; Langer O
Pharm Res; 2021 Jan; 38(1):127-140. PubMed ID: 33559045
[TBL] [Abstract][Full Text] [Related]
10. Stereoselectivity in Cell Uptake by SLC22 Organic Cation Transporters 1, 2, and 3.
Gebauer L; Jensen O; Rafehi M; Brockmöller J
J Med Chem; 2023 Dec; 66(23):15990-16001. PubMed ID: 38052451
[TBL] [Abstract][Full Text] [Related]
11. OCT1-dependent uptake of structurally diverse pyrrolizidine alkaloids in human liver cells is crucial for their genotoxic and cytotoxic effects.
Haas M; Ackermann G; Küpper JH; Glatt H; Schrenk D; Fahrer J
Arch Toxicol; 2023 Dec; 97(12):3259-3271. PubMed ID: 37676300
[TBL] [Abstract][Full Text] [Related]
12. Global genetic analyses reveal strong inter-ethnic variability in the loss of activity of the organic cation transporter OCT1.
Seitz T; Stalmann R; Dalila N; Chen J; Pojar S; Dos Santos Pereira JN; Krätzner R; Brockmöller J; Tzvetkov MV
Genome Med; 2015; 7(1):56. PubMed ID: 26157489
[TBL] [Abstract][Full Text] [Related]
13. The full spectrum of SLC22 OCT1 mutations illuminates the bridge between drug transporter biophysics and pharmacogenomics.
Yee SW; Macdonald CB; Mitrovic D; Zhou X; Koleske ML; Yang J; Buitrago Silva D; Rockefeller Grimes P; Trinidad DD; More SS; Kachuri L; Witte JS; Delemotte L; Giacomini KM; Coyote-Maestas W
Mol Cell; 2024 May; 84(10):1932-1947.e10. PubMed ID: 38703769
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of polyspecific drug binding and transport by OCT1 and OCT2.
Suo Y; Wright NJ; Guterres H; Fedor JG; Butay KJ; Borgnia MJ; Im W; Lee SY
bioRxiv; 2023 Mar; ():. PubMed ID: 36993738
[TBL] [Abstract][Full Text] [Related]
15. The Interaction of Organic Cation Transporters 1-3 and PMAT with Psychoactive Substances.
Maier J; Niello M; Rudin D; Daws LC; Sitte HH
Handb Exp Pharmacol; 2021; 266():199-214. PubMed ID: 33993413
[TBL] [Abstract][Full Text] [Related]
16. Interaction of systemic drugs causing ocular toxicity with organic cation transporter: an artificial intelligence prediction.
Malani M; Hiremath MS; Sharma S; Jhunjhunwala M; Gayen S; Hota C; Nirmal J
J Biomol Struct Dyn; 2024 Jul; 42(10):5207-5218. PubMed ID: 37340665
[TBL] [Abstract][Full Text] [Related]
17. Ligand-dependent modulation of hOCT1 transport reveals discrete ligand binding sites within the substrate translocation channel.
Boxberger KH; Hagenbuch B; Lampe JN
Biochem Pharmacol; 2018 Oct; 156():371-384. PubMed ID: 30138624
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma.
Schaeffeler E; Hellerbrand C; Nies AT; Winter S; Kruck S; Hofmann U; van der Kuip H; Zanger UM; Koepsell H; Schwab M
Genome Med; 2011 Dec; 3(12):82. PubMed ID: 22196450
[TBL] [Abstract][Full Text] [Related]
19. The full spectrum of OCT1 (SLC22A1) mutations bridges transporter biophysics to drug pharmacogenomics.
Yee SW; Macdonald C; Mitrovic D; Zhou X; Koleske ML; Yang J; Silva DB; Grimes PR; Trinidad D; More SS; Kachuri L; Witte JS; Delemotte L; Giacomini KM; Coyote-Maestas W
bioRxiv; 2023 Jun; ():. PubMed ID: 37333090
[TBL] [Abstract][Full Text] [Related]
20. A Novel Milli-fluidic Liver Tissue Chip with Continuous Recirculation for Predictive Pharmacokinetics Applications.
Rajan SAP; Sherfey J; Ohri S; Nichols L; Smith JT; Parekh P; Kadar EP; Clark F; George BT; Gregory L; Tess D; Gosset JR; Liras J; Geishecker E; Obach RS; Cirit M
AAPS J; 2023 Oct; 25(6):102. PubMed ID: 37891356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
